Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;34(2):403-422.
doi: 10.1007/s00787-024-02475-x. Epub 2024 May 29.

Effects of repetitive transcranial magnetic stimulation in children and young people with psychiatric disorders: a systematic review

Lucy Gallop  1 , Samuel J Westwood  2   3 , Amelia Hemmings  4 , Yael Lewis  4   5   6 , Iain C Campbell  4 , Ulrike Schmidt  4   7
Affiliations

Effects of repetitive transcranial magnetic stimulation in children and young people with psychiatric disorders: a systematic review

Lucy Gallop et al. Eur Child Adolesc Psychiatry. 2025 Feb.

Abstract

Repetitive transcranial magnetic stimulation (rTMS) has demonstrated benefits in adults with psychiatric disorders, but its clinical utility in children and young people (CYP) is unclear. This PRISMA systematic review used published and ongoing studies to examine the effects of rTMS on disorder-specific symptoms, mood and neurocognition in CYP with psychiatric disorders. We searched Medline via PubMed, Embase, PsychINFO via OVID, and Clinicaltrials.gov up to July 2023. Eligible studies involved multiple-session (i.e., treatment) rTMS in CYP (≤ 25 years-old) with psychiatric disorders. Two independent raters assessed the eligibility of studies and extracted data using a custom-built form. Out of 78 eligible studies (participant N = 1389), the majority (k = 54; 69%) reported an improvement in at least one outcome measure of disorder-specific core symptoms. Some studies (k = 21) examined rTMS effects on mood or neurocognition,: findings were largely positive. Overall, rTMS was well-tolerated with minimal side-effects. Of 17 ongoing or recently completed studies, many are sham-controlled RCTs with better blinding techniques and a larger estimated participant enrolment. Findings provide encouraging evidence for rTMS-related improvements in disorder-specific symptoms in CYP with different psychiatric disorders. However, in terms of both mood (for conditions other than depression) and neurocognitive outcomes, evidence is limited. Importantly, rTMS is well-tolerated and safe. Ongoing studies appear to be of improved methodological quality; however, future studies should broaden outcome measures to more comprehensively assess the effects of rTMS and develop guidance on dosage (i.e., treatment regimens).

Keywords: Children; Psychiatric disorders; Systematic review; Young people; rTMS.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of selected studies (n = number of articles). A total of 78 studies were systematically reviewed
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Belfer ML (2008) Child and adolescent mental disorders: the magnitude of the problem across the globe. J Child Psychol Psychiatry 49(3):226–236. 10.1111/j.1469-7610.2007.01855.x - PubMed
    1. Kieling C, Baker-Henningham H, Belfer M, Conti G, Ertem I, Omigbodun O, Rohde LA, Srinath S, Ulkuer N, Rahman A (2011) Child and adolescent mental health worldwide: evidence for action. Lancet 378(9801):1515–1525. 10.1016/S0140-6736(11)60827-1 - PubMed
    1. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA (2015) Annual Research Review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry 56(3):345–365. 10.1111/jcpp.12381 - PubMed
    1. Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S (2021) Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a Meta-analysis. JAMA Pediatr 175(11):1142. 10.1001/jamapediatrics.2021.2482 - PMC - PubMed
    1. Ravens-Sieberer U, Erhart M, Devine J, Gilbert M, Reiss F, Barkmann C, Siegel NA, Simon AM, Hurrelmann K, Schlack R, Hölling H, Wieler LH, Kaman A (2022) Child and adolescent Mental Health during the COVID-19 pandemic: results of the three-Wave Longitudinal COPSY Study. J Adolesc Health 71(5):570–578. 10.1016/j.jadohealth.2022.06.022 - PMC - PubMed

Publication types

LinkOut - more resources